About this trial
This study aims to evaluate the diagnostic value of transcranial Doppler ultrasonography (TCD) for evaluating neonatal craniocerebral injuries.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Both sexes.
Critically ill neonates.
Neonatal sepsis.
Neonatal encephalopathy includes hypoxic-ischemic encephalopathy.
Disqualifiers
Congenital malformations.
Genetic metabolic diseases or other severe complications.
Severe intrauterine infection.
Trial population
This prospective observational study will be carried out on 60 neonates admitted to Kafr- Elsheikh University Hospitals over a period of one year starting from approval of the Ethics Committee of Kafr- Elsheikh, Faculty of Medicine and parents of all the included patients will provide written informed consent.
Trial design
Cohort
Prospective
Treatments tested in this trial
Transcranial Doppler ultrasound
DeviceTrans-cranial ultrasound will be carried out for assessment of blood flow velocity in the anterior \[ACA\] and middle cerebral arteries \[MCA\] using duplex pulsed Doppler ultrasound.
Treatment groups
Trial outcomes
Primary outcomes
Sensitivity of transcranial Doppler ultrasound
The sensitivity of transcranial Doppler ultrasound in diagnosing brain injury will be recorded
Sponsors and contacts
Click on the lead sponsor to view all of their trials.